Literature DB >> 407800

Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis.

P G Quie, K L Cates.   

Abstract

Impressive numbers of clinical conditions are associated with defective leukocyte chemotaxis. In many, this cellular dysfunction is associated with other abnormalities of the immune response, but in others abnormal chemotactic responsiveness of leukocytes is the only abnormality of function identified in the laboratory. Patients are usually selected for study because of unusually severe, recurrent infections or poor response to antimicrobial agents, and therefore a frequent association between abnormality of chemotaxis and infection would be expected. Many patients demonstrate abnormal chemotaxis during remissions as well as during infections, and there seems little doubt that abnormality of chemotaxis is related to susceptibility to infections. Partial classification of disorders of chemotaxis was attempted. Major abnormalities are found when there is a primary cellular disorder or cell-directed inhibitors of chemotaxis are found. Less marked abnormalities are found when chemotactic factors are deficient.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407800      PMCID: PMC2032383     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.

Authors:  L C Altman; R Snyderman; R M Blaese
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

2.  Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses.

Authors:  H R Hill; H D Ochs; P G Quie; R A Clark; H F Pabst; S J Klebanoff; R J Wedgwood
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

3.  Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections.

Authors:  H R Hill; P G Quie
Journal:  Lancet       Date:  1974-02-09       Impact factor: 79.321

4.  Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy.

Authors:  D E Van Epps; D L Palmer; R C Williams
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

6.  Bactericidal capacity of monocytes of newborn infants.

Authors:  J P Orlowski; L Sieger; B F Anthony
Journal:  J Pediatr       Date:  1976-11       Impact factor: 4.406

7.  Leukocyte chemotaxis in diabetic patients and their nondiabetic first-degree relatives.

Authors:  D M Molenaar; P J Palumbo; W R Wilson; R E Ritts
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

8.  Histamine release induced by human leukocyte lysates. Reabsorption of previously released histamine after exposure to cyclic amp-active agents.

Authors:  M T Kelly; A White
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  Mannosidosis: clinical, morphologic, immunologic, and biochemical studies.

Authors:  R J Desnick; H L Sharp; G A Grabowski; R D Brunning; P G Quie; J H Sung; R J Gorlin; J U Ikonne
Journal:  Pediatr Res       Date:  1976-12       Impact factor: 3.756

10.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  8 in total

1.  Effect of staphylococcal alpha-toxin on neutrophil migration and adhesiveness.

Authors:  D J Schmeling; C G Gemmell; P R Craddock; P G Quie; P K Peterson
Journal:  Inflammation       Date:  1981-12       Impact factor: 4.092

2.  Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma.

Authors:  J R Walker; D W James; M J Smith
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

3.  Neutrophil adherence, phagocytic-nitroblue tetrazolium reduction and chemiluminescence in canine whole blood.

Authors:  H Nagahata; T Sako; J A Reiter; S P DiBartola; C G Couto; G J Kociba
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

4.  Neutrophil function in infection-prone children.

Authors:  L Håkansson; T Foucard; R Hällgren; P Venge
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

5.  Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.

Authors:  C Dahinden; J Fehr
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

6.  Study of phagocytic function with a quantitative nitroblue-Tetrazolium (NBT) reduction test in diabetes mellitus.

Authors:  M Csató; A Dobozy; N Simon
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

7.  Chemotaxis of porcine neutrophils under agarose.

Authors:  G S Smith; J H Lumsden; B P Wilcock
Journal:  Can J Comp Med       Date:  1985-01

8.  Bovine leukocyte adhesion deficiency in Holstein cattle.

Authors:  H Nagahata; H Nochi; K Tamoto; H Taniyama; H Noda; M Morita; M Kanamaki; G J Kociba
Journal:  Can J Vet Res       Date:  1993-10       Impact factor: 1.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.